---
schema_version: "secwatch.filing_event.v1"
accession: "0001829126-26-006877"
form_type: "8-K"
ticker: null
cik: "0001842138"
company_name: "ULIXE CORP."
filed_at: "2026-06-25T21:20:48+00:00"
generated_at: "2026-06-25T21:22:18.034043+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Ulixe Corp sells Ulixe Nova S.r.l. for €1.00; restructuring ahead of Nasdaq uplisting

## Summary
- Sold 100% equity in Ulixe Nova to Condotti Capital S.r.l. for nominal €1.00 on June 18, 2026.
- Divestiture driven by Ulixe Nova's financial constraints and capital needs; part of strategic reorganization.
- Post-sale structure: Ulixe Italy owns Dale Consulting, Ulixe Pharma, MBSNet; MBSNet owns Fintexa.
- Ulixe Corp previously acquired MBSNet (Nov 2025) to enhance fintech and digital payments capabilities.

## SEC filing metadata
- accession: 0001829126-26-006877
- form_type: 8-K
- cik: 0001842138
- company_name: ULIXE CORP.
- filed_at: 2026-06-25T21:20:48+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1842138/000182912626006877/0001829126-26-006877-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1842138/000182912626006877/ulixecorp_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001829126-26-006877
- JSON: https://secwatch.observer/filing/0001829126-26-006877.json
- Plain text: https://secwatch.observer/filing/0001829126-26-006877.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.